277 related articles for article (PubMed ID: 16466333)
1. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA
Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of nesiritide in pediatric heart failure.
Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
[TBL] [Abstract][Full Text] [Related]
3. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
DeWald TA; Hernandez AF
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
[TBL] [Abstract][Full Text] [Related]
6. Nesiritide: harmful or harmless?
Dorsch MP; Rodgers JE
Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
[TBL] [Abstract][Full Text] [Related]
7. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
Emerman CL
Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
[TBL] [Abstract][Full Text] [Related]
10. Nesiritide use in pediatric patients with congestive heart failure.
Feingold B; Law YM
J Heart Lung Transplant; 2004 Dec; 23(12):1455-9. PubMed ID: 15607680
[TBL] [Abstract][Full Text] [Related]
11. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
Munger MA; Ng TM; Van Tassell BW
Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
[TBL] [Abstract][Full Text] [Related]
12. Nesiritide: trials and tribulations.
Arora RR
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
[TBL] [Abstract][Full Text] [Related]
13. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
14. Nesiritide therapy in a term neonate with renal disease.
Moffett BS; Jefferies JL; Rossano J; Towbin JA
Pharmacotherapy; 2006 Feb; 26(2):281-4. PubMed ID: 16466334
[TBL] [Abstract][Full Text] [Related]
15. Short and long-term mortality with nesiritide.
Arora RR; Venkatesh PK; Molnar J
Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
[TBL] [Abstract][Full Text] [Related]
16. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
17. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
[TBL] [Abstract][Full Text] [Related]
18. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
Riter HG; Redfield MM; Burnett JC; Chen HH
J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
[No Abstract] [Full Text] [Related]
19. Perioperative effects and safety of nesiritide following cardiac surgery in children.
Simsic JM; Scheurer M; Tobias JD; Berkenbosch J; Schechter W; Madera F; Weinstein S; Michler RE
J Intensive Care Med; 2006; 21(1):22-6. PubMed ID: 16698741
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience with nesiritide in pediatric patients less than 12 months of age.
Ryan A; Rosen DA; Tobias JD
J Intensive Care Med; 2008; 23(5):321-8. PubMed ID: 18603536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
